Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 681

1.

Evaluation of [18F]pitavastatin as a positron emission tomography tracer for in vivo organic transporter polypeptide function.

Yagi Y, Kimura H, Okuda H, Ono M, Nakamoto Y, Togashi K, Saji H.

Nucl Med Biol. 2019 Aug 14;74-75:25-31. doi: 10.1016/j.nucmedbio.2019.08.001. [Epub ahead of print]

PMID:
31450072
2.

Current status of clinical proteogenomics in lung cancer.

Nishimura T, Nakamura H, Végvári Á, Marko-Varga G, Furuya N, Saji H.

Expert Rev Proteomics. 2019 Sep;16(9):761-772. doi: 10.1080/14789450.2019.1654861. Epub 2019 Aug 21.

PMID:
31402712
3.

Development of 99mTc radiolabeled A85380 derivatives targeting cerebral nicotinic acetylcholine receptor: Novel radiopharmaceutical ligand 99mTc-A-YN-IDA-C4.

Mori D, Kimura H, Kawashima H, Yagi Y, Arimitsu K, Ono M, Saji H.

Bioorg Med Chem. 2019 Sep 15;27(18):4200-4210. doi: 10.1016/j.bmc.2019.07.053. Epub 2019 Jul 31.

PMID:
31401009
4.

Noninvasive longitudinal quantification of β-cell mass with [111In]-labeled exendin-4.

Fujita N, Fujimoto H, Hamamatsu K, Murakami T, Kimura H, Toyoda K, Saji H, Inagaki N.

FASEB J. 2019 Aug 1:fj201900555RR. doi: 10.1096/fj.201900555RR. [Epub ahead of print]

PMID:
31370679
5.

High-Risk Factors for Recurrence of Stage I Lung Adenocarcinoma: Follow-up Data from JCOG0201.

Tsutani Y, Suzuki K, Koike T, Wakabayashi M, Mizutani T, Aokage K, Saji H, Nakagawa K, Zenke Y, Takamochi K, Ito H, Aoki T, Okami J, Yoshioka H, Okada M, Watanabe SI; Japan Clinical Oncology Group Lung Cancer Surgical Study Group (JCOG-LCSSG).

Ann Thorac Surg. 2019 Jul 20. pii: S0003-4975(19)31046-X. doi: 10.1016/j.athoracsur.2019.05.080. [Epub ahead of print]

PMID:
31336067
6.

Evaluation of transporter-mediated hepatobiliary transport of newly developed 18F-labeled pitavastatin derivative, PTV-F1, in rats by PET imaging.

Kimura H, Yagi Y, Mikamo M, Kazuya M, Kagawa S, Arimitsu K, Higashi T, Nishii R, Ono M, Nakamoto Y, Togashi K, Kusuhara H, Saji H.

Drug Metab Pharmacokinet. 2019 Jun 4. pii: S1347-4367(19)30033-3. doi: 10.1016/j.dmpk.2019.05.006. [Epub ahead of print]

PMID:
31331824
7.

In Vivo Imaging of Nicotinic Acetylcholine Receptors in the Central Nervous System.

Ueda M, Matsuura Y, Hosoda R, Saji H.

In: Akaike A, Shimohama S, Misu Y, editors. Nicotinic Acetylcholine Receptor Signaling in Neuroprotection [Internet]. Singapore: Springer; 2018. Chapter 2.
2018 Apr 4.

8.

Correction to: Successful adjustment for self-expanding metallic stent migration using a flexible bronchoscope with two biopsy forceps technique.

Yoneyama R, Saji H, Makino Y, Kato Y, Kajiwara N, Ohira T, Ikeda N.

Gen Thorac Cardiovasc Surg. 2019 Sep;67(9):821. doi: 10.1007/s11748-019-01167-7.

PMID:
31292848
9.

18F-labeled benzimidazopyridine derivatives for PET imaging of tau pathology in Alzheimer's disease.

Kaide S, Watanabe H, Shimizu Y, Tatsumi H, Iikuni S, Nakamoto Y, Togashi K, Ihara M, Saji H, Ono M.

Bioorg Med Chem. 2019 Aug 15;27(16):3587-3594. doi: 10.1016/j.bmc.2019.06.039. Epub 2019 Jun 26.

PMID:
31285098
10.

Development of Technetium-99m-Labeled BODIPY-Based Probes Targeting Lipid Droplets Toward the Diagnosis of Hyperlipidemia-Related Diseases.

Shimizu Y, Tanimura K, Iikuni S, Watanabe H, Saji H, Ono M.

Molecules. 2019 Jun 19;24(12). pii: E2283. doi: 10.3390/molecules24122283.

11.

Identification of key modules and hub genes for small-cell lung carcinoma and large-cell neuroendocrine lung carcinoma by weighted gene co-expression network analysis of clinical tissue-proteomes.

Nakamura H, Fujii K, Gupta V, Hata H, Koizumu H, Hoshikawa M, Naruki S, Miyata Y, Takahashi I, Miyazawa T, Sakai H, Tsumoto K, Takagi M, Saji H, Nishimura T.

PLoS One. 2019 Jun 5;14(6):e0217105. doi: 10.1371/journal.pone.0217105. eCollection 2019.

12.

Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial.

Suzuki K, Saji H, Aokage K, Watanabe SI, Okada M, Mizusawa J, Nakajima R, Tsuboi M, Nakamura S, Nakamura K, Mitsudomi T, Asamura H; West Japan Oncology Group; Japan Clinical Oncology Group.

J Thorac Cardiovasc Surg. 2019 Sep;158(3):895-907. doi: 10.1016/j.jtcvs.2019.03.090. Epub 2019 Apr 9.

PMID:
31078312
13.

Does the extension of the type of hysterectomy contribute to the local control of endometrial cancer?

Hasegawa T, Furugori M, Kubota K, Asai-Sato M, Yashiro-Kawano A, Kato H, Oi Y, Shigeta H, Segawa K, Kitagawa M, Mine Y, Saji H, Numazaki R, Maruyama Y, Ohnuma E, Taniguchi H, Sugiura K, Miyagi E, Matsunaga T; Yokohama City University Gynecologic Oncology Research Group (YCUGO-ReG).

Int J Clin Oncol. 2019 Sep;24(9):1129-1136. doi: 10.1007/s10147-019-01458-2. Epub 2019 May 8.

14.

Synthesis and biological evaluation of F-18 labeled tetrahydroisoquinoline derivatives targeting orexin 1 receptor.

Watanabe H, Fukui K, Shimizu Y, Idoko Y, Nakamoto Y, Togashi K, Saji H, Ono M.

Bioorg Med Chem Lett. 2019 Jul 1;29(13):1620-1623. doi: 10.1016/j.bmcl.2019.04.044. Epub 2019 Apr 27.

PMID:
31056243
15.

Synthesis of a Novel Pyrazine⁻Pyridone Biheteroaryl-Based Fluorescence Sensor and Detection of Endogenous Labile Zinc Ions in Lung Cancer Cells.

Hagimori M, Taniura M, Mizuyama N, Karimine Y, Kawakami S, Saji H, Mukai T.

Sensors (Basel). 2019 May 2;19(9). pii: E2049. doi: 10.3390/s19092049.

16.

Synthesis and biological evaluation of Tc-99m-cyclopentadienyltricarbonyl-technetium-labeled A-85380: An imaging probe for single-photon emission computed tomography investigation of nicotinic acetylcholine receptors in the brain.

Kimura H, Ueda M, Kawashima H, Arimitsu K, Yagi Y, Saji H.

Bioorg Med Chem. 2019 Jun 1;27(11):2245-2252. doi: 10.1016/j.bmc.2019.04.030. Epub 2019 Apr 25.

PMID:
31047775
17.

Clinicopathological characteristics and treatment strategies for young lung cancer patients.

Yoneyama R, Saji H, Kato Y, Kudo Y, Shimada Y, Kimura M, Hagiwara M, Kakihana M, Miyajima K, Kajiwara N, Ohira T, Kato H, Ikeda N.

Ann Transl Med. 2019 Mar;7(5):100. doi: 10.21037/atm.2019.01.69.

18.

Cytological differences between invasive and noninvasive or minimally invasive lung adenocarcinomas diagnosed in Japanese patients using needle biopsy specimens of pulmonary lesions ≤3 cm in diameter.

Matsubayashi J, Miyake S, Kudo Y, Shimada Y, Maeda J, Saji H, Kakihana M, Park J, Kajiwara N, Inoue S, Saito K, Ohira T, Ikeda N, Tokuuye K, Nagao T.

Diagn Cytopathol. 2019 Jul;47(7):688-694. doi: 10.1002/dc.24171. Epub 2019 Apr 9.

19.

Development of the 99mTc-Hydroxamamide Complex as a Probe Targeting Carbonic Anhydrase IX.

Iikuni S, Tanimura K, Watanabe H, Shimizu Y, Saji H, Ono M.

Mol Pharm. 2019 Apr 1;16(4):1489-1497. doi: 10.1021/acs.molpharmaceut.8b01120. Epub 2019 Mar 20.

PMID:
30892905
20.

Initial evaluation of PET/CT with 18 F-FSU-880 targeting prostate-specific membrane antigen in prostate cancer patients.

Saga T, Nakamoto Y, Ishimori T, Inoue T, Shimizu Y, Kimura H, Akamatsu S, Goto T, Watanabe H, Kitaguchi K, Watanabe M, Ono M, Saji H, Ogawa O, Togashi K.

Cancer Sci. 2019 Feb;110(2):742-750. doi: 10.1111/cas.13911. Epub 2019 Jan 4.

21.

The Society for Translational Medicine: indications and methods of percutaneous transthoracic needle biopsy for diagnosis of lung cancer.

Zhou Q, Dong J, He J, Liu D, Tian DH, Gao S, Li S, Liu L, He J, Huang Y, Xu S, Mao W, Tan Q, Chen C, Li X, Zhang Z, Jiang G, Xu L, Zhang L, Fu J, Li H, Wang Q, Tan L, Li D, Zhou Q, Fu X, Jiang Z, Chen H, Fang W, Zhang X, Li Y, Tong T, Yu Z, Liu Y, Zhi X, Yan T, Zhang X, Casal RF, Pompeo E, Carretta A, Riquet M, Rena O, Falcoz PE, Saji H, Khan AZ, Danguilan JL, Gonzalez-Rivas D, Guibert N, Zhu C, Shen J.

J Thorac Dis. 2018 Sep;10(9):5538-5544. doi: 10.21037/jtd.2018.09.28. Review. No abstract available.

22.

Characterization of Novel 18F-Labeled Phenoxymethylpyridine Derivatives as Amylin Imaging Probes.

Watanabe H, Yoshimura M, Sano K, Shimizu Y, Kaide S, Nakamoto Y, Togashi K, Ono M, Saji H.

Mol Pharm. 2018 Dec 3;15(12):5574-5584. doi: 10.1021/acs.molpharmaceut.8b00756. Epub 2018 Nov 8.

PMID:
30407835
23.

Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation.

Yokoyama H, Kanda J, Kato S, Kondo E, Maeda Y, Saji H, Takahashi S, Onizuka M, Onishi Y, Ozawa Y, Kanamori H, Ishikawa J, Ohno Y, Ichinohe T, Takanashi M, Kato K, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2019 Jul;54(7):1004-1012. doi: 10.1038/s41409-018-0369-0. Epub 2018 Nov 6.

PMID:
30401965
24.

PD-L1 Expression in Non-Small-Cell Lung Cancer Including Various Adenocarcinoma Subtypes.

Miyazawa T, Marushima H, Saji H, Kojima K, Hoshikawa M, Takagi M, Nakamura H.

Ann Thorac Cardiovasc Surg. 2019 Feb 20;25(1):1-9. doi: 10.5761/atcs.oa.18-00163. Epub 2018 Oct 3.

25.

A variant at 9q34.11 is associated with HLA-DQB1*06:02 negative essential hypersomnia.

Miyagawa T, Khor SS, Toyoda H, Kanbayashi T, Imanishi A, Sagawa Y, Kotorii N, Kotorii T, Ariyoshi Y, Hashizume Y, Ogi K, Hiejima H, Kamei Y, Hida A, Miyamoto M, Ikegami A, Wada Y, Takami M, Higashiyama Y, Miyake R, Kondo H, Fujimura Y, Tamura Y, Taniyama Y, Omata N, Tanaka Y, Moriya S, Furuya H, Kato M, Kawamura Y, Otowa T, Miyashita A, Kojima H, Saji H, Shimada M, Yamasaki M, Kobayashi T, Misawa R, Shigematsu Y, Kuwano R, Sasaki T, Ishigooka J, Wada Y, Tsuruta K, Chiba S, Tanaka F, Yamada N, Okawa M, Kuroda K, Kume K, Hirata K, Uchimura N, Shimizu T, Inoue Y, Honda Y, Mishima K, Honda M, Tokunaga K.

J Hum Genet. 2018 Dec;63(12):1259-1267. doi: 10.1038/s10038-018-0518-8. Epub 2018 Sep 28.

PMID:
30266950
26.

Novel fluorescence probes based on the chalcone scaffold for in vitro staining of β-amyloid plaques.

Watanabe H, Saji H, Ono M.

Bioorg Med Chem Lett. 2018 Oct 15;28(19):3242-3246. doi: 10.1016/j.bmcl.2018.08.009. Epub 2018 Aug 8.

PMID:
30131243
27.

Evaluation of the Relationship Between Cognitive Impairment, Glycometabolism, and Nicotinic Acetylcholine Receptor Deficits in a Mouse Model of Alzheimer's Disease.

Matsuura Y, Ueda M, Higaki Y, Sano K, Saji H, Enomoto S.

Mol Imaging Biol. 2019 Jun;21(3):519-528. doi: 10.1007/s11307-018-1253-4.

PMID:
30047036
28.

Enhanced Delivery of Radiolabeled Polyoxazoline into Tumors via Self-Aggregation under Hyperthermic Conditions.

Sano K, Kanada Y, Takahashi K, Ding N, Kanazaki K, Mukai T, Ono M, Saji H.

Mol Pharm. 2018 Sep 4;15(9):3997-4003. doi: 10.1021/acs.molpharmaceut.8b00441. Epub 2018 Aug 13.

PMID:
30036483
29.

Establishment of a method for in-vivo SPECT/CT imaging analysis of 111In-labeled exendin-4 pancreatic uptake in mice without the need for nephrectomy or a secondary probe.

Hamamatsu K, Fujimoto H, Fujita N, Murakami T, Kimura H, Saji H, Inagaki N.

Nucl Med Biol. 2018 Sep - Oct;64-65:22-27. doi: 10.1016/j.nucmedbio.2018.06.002. Epub 2018 Jun 8.

PMID:
30015092
30.

Synthesis and evaluation of a [18F]formyl-Met-Leu-Phe derivative: A positron emission tomography imaging probe for bacterial infections.

Kimura H, Yamauchi S, Kawashima H, Arimitsu K, Yagi Y, Nakamoto Y, Togashi K, Ono M, Saji H.

Bioorg Med Chem Lett. 2018 Sep 15;28(17):2949-2952. doi: 10.1016/j.bmcl.2018.07.009. Epub 2018 Jul 6.

PMID:
30006064
31.

Cancer radiotheranostics targeting carbonic anhydrase-IX with 111In- and 90Y-labeled ureidosulfonamide scaffold for SPECT imaging and radionuclide-based therapy.

Iikuni S, Ono M, Watanabe H, Shimizu Y, Sano K, Saji H.

Theranostics. 2018 Apr 30;8(11):2992-3006. doi: 10.7150/thno.20982. eCollection 2018.

32.

Differential Proteomic Analysis between Small Cell Lung Carcinoma (SCLC) and Pulmonary Carcinoid Tumors Reveals Molecular Signatures for Malignancy in Lung Cancer.

Fujii K, Miyata Y, Takahashi I, Koizumi H, Saji H, Hoshikawa M, Takagi M, Nishimura T, Nakamura H.

Proteomics Clin Appl. 2018 Nov;12(6):e1800015. doi: 10.1002/prca.201800015. Epub 2018 Jul 5.

PMID:
29888431
33.

Activatable fluorescence imaging of macrophages in atherosclerotic plaques using iron oxide nanoparticles conjugated with indocyanine green.

Ikeda H, Ishii A, Sano K, Chihara H, Arai D, Abekura Y, Nishi H, Ono M, Saji H, Miyamoto S.

Atherosclerosis. 2018 Aug;275:1-10. doi: 10.1016/j.atherosclerosis.2018.05.028. Epub 2018 May 18.

PMID:
29852399
34.

Improved lymph node staging in early-stage lung cancer in the national cancer database: commentary.

Saji H, Kojima K, Nakamura H.

J Thorac Dis. 2018 Apr;10(Suppl 9):S1092-S1095. doi: 10.21037/jtd.2018.04.36. No abstract available.

35.

Structure-Activity Relationships of Radioiodinated Benzoimidazopyridine Derivatives for Detection of Tau Pathology.

Kaide S, Ono M, Watanabe H, Kitada A, Yoshimura M, Shimizu Y, Ihara M, Saji H.

ACS Med Chem Lett. 2018 Apr 10;9(5):478-483. doi: 10.1021/acsmedchemlett.8b00092. eCollection 2018 May 10.

36.

Conversion of iodine to fluorine-18 based on iodinated chalcone and evaluation for β-amyloid PET imaging.

Kaide S, Ono M, Watanabe H, Shimizu Y, Nakamoto Y, Togashi K, Yamaguchi A, Hanaoka H, Saji H.

Bioorg Med Chem. 2018 Jul 23;26(12):3352-3358. doi: 10.1016/j.bmc.2018.05.001. Epub 2018 May 3.

PMID:
29751990
37.

Allelic Polymorphisms of KIRs and HLAs Predict Favorable Responses to Tyrosine Kinase Inhibitors in CML.

Ureshino H, Shindo T, Kojima H, Kusunoki Y, Miyazaki Y, Tanaka H, Saji H, Kawaguchi A, Kimura S.

Cancer Immunol Res. 2018 Jun;6(6):745-754. doi: 10.1158/2326-6066.CIR-17-0462. Epub 2018 Apr 25.

38.

Comparison of 125I- and 111In-labeled peptide probes for in vivo detection of oxidized low-density lipoprotein in atherosclerotic plaques.

Temma T, Kondo N, Yoda K, Nishigori K, Onoe S, Shiomi M, Ono M, Saji H.

Ann Nucl Med. 2018 Jul;32(6):425-429. doi: 10.1007/s12149-018-1255-y. Epub 2018 Apr 12.

PMID:
29651757
39.

Prognostic factors for surgically resected non-small cell lung cancer with cavity formation.

Shigefuku S, Kudo Y, Yunaiyama D, Matsubayashi J, Park J, Nagao T, Shimada Y, Saji H, Hagiwara M, Okano T, Kakihana M, Kajiwara N, Ohira T, Ikeda N.

J Thorac Dis. 2018 Feb;10(2):973-983. doi: 10.21037/jtd.2018.01.61.

40.

Structure-activity relationships of succinimidyl-Cys-C(O)-Glu derivatives with different near-infrared fluorophores as optical imaging probes for prostate-specific membrane antigen.

Matsuoka D, Watanabe H, Shimizu Y, Kimura H, Yagi Y, Kawai R, Ono M, Saji H.

Bioorg Med Chem. 2018 May 15;26(9):2291-2301. doi: 10.1016/j.bmc.2018.03.015. Epub 2018 Mar 10.

PMID:
29580851
41.

PET probe detecting non-small cell lung cancer susceptible to epidermal growth factor receptor tyrosine kinase inhibitor therapy.

Makino A, Miyazaki A, Tomoike A, Kimura H, Arimitsu K, Hirata M, Ohmomo Y, Nishii R, Okazawa H, Kiyono Y, Ono M, Saji H.

Bioorg Med Chem. 2018 May 1;26(8):1609-1613. doi: 10.1016/j.bmc.2018.02.007. Epub 2018 Feb 8.

PMID:
29478801
42.

18F-FPYBF-2, a new F-18 labelled amyloid imaging PET tracer: biodistribution and radiation dosimetry assessment of first-in-man 18F-FPYBF-2 PET imaging.

Nishii R, Higashi T, Kagawa S, Okuyama C, Kishibe Y, Takahashi M, Okina T, Suzuki N, Hasegawa H, Nagahama Y, Ishizu K, Oishi N, Kimura H, Watanabe H, Ono M, Saji H, Yamauchi H.

Ann Nucl Med. 2018 May;32(4):256-263. doi: 10.1007/s12149-018-1240-5. Epub 2018 Feb 16.

PMID:
29453681
43.

HLA-DRB1 Analysis Identified a Genetically Unique Subset within Rheumatoid Arthritis and Distinct Genetic Background of Rheumatoid Factor Levels from Anticyclic Citrullinated Peptide Antibodies.

Hiwa R, Ikari K, Ohmura K, Nakabo S, Matsuo K, Saji H, Yurugi K, Miura Y, Maekawa T, Taniguchi A, Yamanaka H, Matsuda F, Mimori T, Terao C.

J Rheumatol. 2018 Apr;45(4):470-480. doi: 10.3899/jrheum.170363. Epub 2018 Feb 1.

PMID:
29419463
44.

18F-FPYBF-2, a new F-18-labelled amyloid imaging PET tracer: first experience in 61 volunteers and 55 patients with dementia.

Higashi T, Nishii R, Kagawa S, Kishibe Y, Takahashi M, Okina T, Suzuki N, Hasegawa H, Nagahama Y, Ishizu K, Oishi N, Kimura H, Watanabe H, Ono M, Saji H, Yamauchi H.

Ann Nucl Med. 2018 Apr;32(3):206-216. doi: 10.1007/s12149-018-1236-1. Epub 2018 Jan 31.

45.

Core Binding Site of a Thioflavin-T-Derived Imaging Probe on Amyloid β Fibrils Predicted by Computational Methods.

Kawai R, Araki M, Yoshimura M, Kamiya N, Ono M, Saji H, Okuno Y.

ACS Chem Neurosci. 2018 May 16;9(5):957-966. doi: 10.1021/acschemneuro.7b00389. Epub 2018 Jan 30.

PMID:
29381047
46.

Evaluation of 18F-labeled exendin(9-39) derivatives targeting glucagon-like peptide-1 receptor for pancreatic β-cell imaging.

Kimura H, Ogawa Y, Fujimoto H, Mukai E, Kawashima H, Arimitsu K, Toyoda K, Fujita N, Yagi Y, Hamamatsu K, Murakami T, Murakami A, Ono M, Nakamoto Y, Togashi K, Inagaki N, Saji H.

Bioorg Med Chem. 2018 Jan 15;26(2):463-469. doi: 10.1016/j.bmc.2017.12.007. Epub 2017 Dec 5.

PMID:
29273416
47.

A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303.

Saji H, Ueno T, Nakamura H, Okumura N, Tsuchida M, Sonobe M, Miyazaki T, Aokage K, Nakao M, Haruki T, Ito H, Kataoka K, Okabe K, Tomizawa K, Yoshimoto K, Horio H, Sugio K, Ode Y, Takao M, Okada M, Chida M; Committee for Scientific Affairs, The Japanese Association for Chest Surgery, Tokyo, Japan.

Eur J Cardiothorac Surg. 2018 Apr 1;53(4):835-841. doi: 10.1093/ejcts/ezx415.

PMID:
29240884
48.

Worse survival after curative resection in patients with pathological stage I non-small cell lung cancer adjoining pulmonary cavity formation.

Kimura H, Saji H, Miyazawa T, Sakai H, Tsuda M, Wakiyama Y, Marushima H, Kojima K, Nakamura H.

J Thorac Dis. 2017 Sep;9(9):3038-3044. doi: 10.21037/jtd.2017.08.42.

49.

Flumioxazin metabolism in pregnant animals and cell-based protoporphyrinogen IX oxidase (PPO) inhibition assay of fetal metabolites in various animal species to elucidate the mechanism of the rat-specific developmental toxicity.

Abe J, Isobe N, Mikata K, Nagahori H, Naito Y, Saji H, Ono M, Kawamura S.

Toxicol Appl Pharmacol. 2018 Jan 15;339:34-41. doi: 10.1016/j.taap.2017.11.028. Epub 2017 Dec 2.

PMID:
29198728
50.

A randomized Phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I-II non-small cell lung cancer (JCOG1413).

Hishida T, Saji H, Watanabe SI, Asamura H, Aokage K, Mizutani T, Wakabayashi M, Shibata T, Okada M; Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group (JCOG-LCSSG).

Jpn J Clin Oncol. 2018 Feb 1;48(2):190-194. doi: 10.1093/jjco/hyx170.

PMID:
29177507

Supplemental Content

Support Center